Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation
Date
2025-11-12
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
MacDonald, K V, Heidenreich, S, Krucien, N, Boycott, K M, Bernier, F P, Ryan, M & Marshall, D A 2025, 'Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation', European Journal of Health Economics. https://doi.org/10.1007/s10198-025-01870-8